Stifel raises Alnylam Pharmaceuticals stock price target to $495 on strong Vutrisiran sales

Investing.comMonday, October 6, 2025 at 2:11:33 PM
Stifel raises Alnylam Pharmaceuticals stock price target to $495 on strong Vutrisiran sales
Stifel has raised its price target for Alnylam Pharmaceuticals to $495, driven by strong sales of Vutrisiran. This increase reflects confidence in the company's growth and the effectiveness of its products, which is great news for investors and the market. As Vutrisiran continues to perform well, it highlights Alnylam's position in the pharmaceutical industry and its potential for future success.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Stifel reiterates Buy rating on Gambling.com stock, maintains $15 target
PositiveFinancial Markets
Stifel has reaffirmed its Buy rating on Gambling.com stock, maintaining a target price of $15. This is significant as it reflects confidence in the company's growth potential in the online gambling sector, which continues to expand rapidly. Investors may find this a promising opportunity, especially as the market evolves and more states legalize online gambling.
Stifel reiterates Datadog stock Hold rating amid OpenAI contract renewal
NeutralFinancial Markets
Stifel has maintained its Hold rating on Datadog's stock as the company navigates the renewal of its contract with OpenAI. This decision reflects a cautious approach amid ongoing developments in the tech sector. Investors are keenly watching how this contract renewal will impact Datadog's performance and market position, making it a significant point of interest for those involved in tech investments.
Stifel reiterates Buy rating on Okta stock, maintains $130 price target
PositiveFinancial Markets
Stifel has reaffirmed its Buy rating on Okta's stock and is maintaining a price target of $130. This is significant as it reflects confidence in Okta's growth potential and market position, which could encourage investors to consider the stock as a viable option for their portfolios.
Stifel raises Ionis Pharmaceuticals stock price target to $67 from $43
PositiveFinancial Markets
Stifel has raised its price target for Ionis Pharmaceuticals from $43 to $67, reflecting a positive outlook on the company's future performance. This adjustment indicates confidence in Ionis's growth potential and could attract more investors, highlighting the company's advancements in drug development and market position.
IsoEnergy stock rating resumed at Buy by Stifel on dual-market strategy
PositiveFinancial Markets
IsoEnergy has received a positive boost as Stifel has resumed its stock rating at 'Buy', highlighting the company's dual-market strategy. This is significant because it reflects confidence in IsoEnergy's potential for growth and profitability, especially in a competitive market. Investors may see this as a strong indicator of the company's future performance.
Latest from Financial Markets
France in fresh political and market turmoil after prime minister resigns
NegativeFinancial Markets
France is facing new political and market instability following the resignation of Prime Minister Sébastien Lecornu. His departure has prompted President Emmanuel Macron to urgently seek a stability plan, highlighting the ongoing challenges in the French government. This situation is significant as it could impact economic policies and public confidence in leadership during a critical time.
Ecopetrol Plans Another LNG Import Terminal in Colombia at Port
PositiveFinancial Markets
Ecopetrol is moving forward with plans to establish a new liquefied natural gas import terminal at a Colombian port, addressing the country's increasing fuel shortfall. This initiative is significant as it aims to enhance energy security and meet the rising demand for natural gas in Colombia, which is crucial for both residential and industrial use.
U.S. Warehouse Vacancies Steady as Demand Rises With Less New Space
NeutralFinancial Markets
In the third quarter, the U.S. warehouse vacancy rate remained stable at an 11-year high, marking a significant shift as it did not increase for the first time in three years. This stability comes amidst rising demand for warehouse space, even as the construction of new facilities continues to decline. This trend is important as it reflects the changing dynamics in the logistics and supply chain sectors, indicating a potential shift in how businesses are managing their storage needs.
Citadel's Esposito Says Firm Focused on Fixed Income
PositiveFinancial Markets
Citadel Securities is making strides in the finance sector by partnering with small and mid-tier banks to enhance their trading capabilities in fixed-income securities. President Jim Esposito highlighted this initiative during an appearance on Bloomberg Television, emphasizing the firm's commitment to providing better pricing options for these banks. This move not only strengthens Citadel's position in the market but also supports smaller financial institutions in accessing competitive trading opportunities, which is crucial for their growth and stability.
Argentina Sells Dollars for 5th Day as Treasury Drains Reserves
NeutralFinancial Markets
Argentina's government has been actively selling dollars in the foreign-exchange market for the fifth consecutive day, aiming to stabilize the declining peso. This move is significant as it reflects the government's efforts to manage economic challenges and maintain currency value, which impacts both local businesses and consumers.
Xcel Energy stock hits all-time high of 81.16 USD
PositiveFinancial Markets
Xcel Energy's stock has reached an all-time high of 81.16 USD, marking a significant milestone for the company and its investors. This surge reflects strong performance and investor confidence in the energy sector, highlighting the company's successful strategies and growth potential. Such achievements are crucial as they not only boost shareholder value but also signal a positive outlook for the energy market.